Related Experiment Video
Updated: Aug 11, 2026
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder
Herbert M Lachman1, Pavla Stopkova, Demitri F Papolos
1Department of Psychiatry and Behavioral Sciences, Division of Psychiatry Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Lachman@aecom.yu.edu
Background:
The 22q13-linked gene synapsin III is a positional candidate gene for schizophrenia (SZ). One interesting synapsin III single nucleotide polymorphism (SNP), -196G/A, has been identified in the promoter region. The -196A allele results in a 6/8 base match to the core recognition octamer sequence for Oct-1, a member of the POU family of transcription factors.
Objective:
To determine whether or not the -196 SNP is associated with either SZ or bipolar disorder (BD).
Methods:
A case control comparison was used to determine whether or not differences in allele or genotype distribution occurred in patients with SZ and BD. Electromobility gel shift assay (EMSA) was used to determine whether the -196 SNP affected protein binding.
Results:
A trend towards significance was detected when the allele distribution was analyzed in Caucasian patients with SZ (n = 145; 191 controls) and a cohort of subjects from the Czech Republic with BD (n = 82; 94 controls). No association was found in bipolar patients from the United States (n = 127) or in African-American patients with SZ (n = 124; 133 controls). EMSA showed that the region encompassing the -196 SNP binds to a brain protein in an allele-specific manner.
Conclusions:
These data, while inconclusive, suggest that -196 SNP should be further investigated as a candidate for 22q13-linked SZ.
